BACKGROUND: Cryoballoon pulmonary vein isolation (PVI) is an alternative to radiofrequency (RF) PVI for the treatment of paroxysmal atrial fibrillation (AF). Treatment effect, complication rates, and hospital length of stay are not well established with early use of cryoballoon PVI as compared to more experienced performance of RF PVI. PURPOSE: We reviewed the early experience of cryoballoon PVIs for paroxysmal AF performed by 3 operators at our institution compared to their most recent RF PVIs. All repeat procedures were excluded. Patients were assessed for recurrence of AF at 6 months after the procedure, including a 3-month blanking period. Complications, procedure time, and hospital length of stay were recorded. METHODS: Consecutive patients presenting to the ER with ECG-documented AF at an urban teaching hospital were treated according to a guideline-based care protocol, including a patient toolkit at ER discharge, and systematic referral to a rapid access AF clinic. Consenting patients received questionnaires on AF knowledge, patient satisfaction, and the AFEQT questionnaire at first visit and three-month follow-up. RESULTS: Final analysis included 50 cryoballoon PVIs and 50 RF PVIs. There was no significant difference in baseline characteristics or percentage of patients wearing a home monitor (80% for cryoballoon vs 80% for RF). Symptomatic improvement was experienced by 96% of cryoballoon PVI as compared to 86% of RF PVI patients (p=0.08). Freedom from AF at 6 months was similar between the two groups (70% for cryoballoon and 70% for RF, p=1). Complications were seen in 6% of cryoballoon procedures as compared to 10% of RF procedures (p=0.46). Hospital length of stay was significantly shorter in the cryoballoon group (1.6 vs 3.4 nights, p=0.003). CONCLUSION: At the time of its adoption, cryoballoon PVI is associated with shorter procedure times and hospital length of stay as compared to RF PVI in experienced operators while maintaining similar efficacy outcomes and complication rates.
BACKGROUND:Cryoballoon pulmonary vein isolation (PVI) is an alternative to radiofrequency (RF) PVI for the treatment of paroxysmal atrial fibrillation (AF). Treatment effect, complication rates, and hospital length of stay are not well established with early use of cryoballoon PVI as compared to more experienced performance of RF PVI. PURPOSE: We reviewed the early experience of cryoballoon PVIs for paroxysmal AF performed by 3 operators at our institution compared to their most recent RF PVIs. All repeat procedures were excluded. Patients were assessed for recurrence of AF at 6 months after the procedure, including a 3-month blanking period. Complications, procedure time, and hospital length of stay were recorded. METHODS: Consecutive patients presenting to the ER with ECG-documented AF at an urban teaching hospital were treated according to a guideline-based care protocol, including a patient toolkit at ER discharge, and systematic referral to a rapid access AF clinic. Consenting patients received questionnaires on AF knowledge, patient satisfaction, and the AFEQT questionnaire at first visit and three-month follow-up. RESULTS: Final analysis included 50 cryoballoon PVIs and 50 RF PVIs. There was no significant difference in baseline characteristics or percentage of patients wearing a home monitor (80% for cryoballoon vs 80% for RF). Symptomatic improvement was experienced by 96% of cryoballoon PVI as compared to 86% of RF PVI patients (p=0.08). Freedom from AF at 6 months was similar between the two groups (70% for cryoballoon and 70% for RF, p=1). Complications were seen in 6% of cryoballoon procedures as compared to 10% of RF procedures (p=0.46). Hospital length of stay was significantly shorter in the cryoballoon group (1.6 vs 3.4 nights, p=0.003). CONCLUSION: At the time of its adoption, cryoballoon PVI is associated with shorter procedure times and hospital length of stay as compared to RF PVI in experienced operators while maintaining similar efficacy outcomes and complication rates.
Authors: Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2014-05-02
Authors: Tobias Reichlin; Sven Knecht; Christopher Lane; Michael Kühne; Eyal Nof; Nagesh Chopra; Thomas M Tadros; Vivek Y Reddy; Beat Schaer; Roy M John; Stefan Osswald; William G Stevenson; Christian Sticherling; Gregory F Michaud Journal: Heart Rhythm Date: 2013-10-28 Impact factor: 6.343
Authors: Alvaro V Sarabanda; T Jared Bunch; Susan B Johnson; Srijoy Mahapatra; Mark A Milton; Luiz R Leite; G Keith Bruce; Douglas L Packer Journal: J Am Coll Cardiol Date: 2005-10-20 Impact factor: 24.094
Authors: Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady Journal: Circulation Date: 2002-03-05 Impact factor: 29.690
Authors: Gunnar Klein; Hanno Oswald; Ajmal Gardiwal; Ulrich Lüsebrink; Christoph Lissel; Hong Yu; Helmut Drexler Journal: Heart Rhythm Date: 2008-02-16 Impact factor: 6.343
Authors: Markus Linhart; Barbara Bellmann; Erica Mittmann-Braun; Jan W Schrickel; Alexander Bitzen; René Andrié; Alexander Yang; Georg Nickenig; Lars Lickfett; Thorsten Lewalter Journal: J Cardiovasc Electrophysiol Date: 2009-12
Authors: Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin Journal: J Am Coll Cardiol Date: 2013-03-21 Impact factor: 24.094
Authors: Thomas Neumann; Jürgen Vogt; Burghard Schumacher; Anja Dorszewski; Malte Kuniss; Hans Neuser; Klaus Kurzidim; Alexander Berkowitsch; Marcus Koller; Johannes Heintze; Ursula Scholz; Ulrike Wetzel; Michael A E Schneider; Dieter Horstkotte; Christian W Hamm; Heinz-Friedrich Pitschner Journal: J Am Coll Cardiol Date: 2008-07-22 Impact factor: 24.094
Authors: Antonio Sorgente; Gian Battista Chierchia; Lucio Capulzini; Yoshinao Yazaki; Andreas Muller-Burri; Fatih Bayrak; Andrea Sarkozy; Carlo de Asmundis; Gaetano Paparella; Brugada Brugada Journal: Indian Pacing Electrophysiol J Date: 2010-12-26
Authors: Jesus M Paylos; Aracelis Morales; Luis Azcona; Marisol Paradela; Raquel Yagüe; Fernando Gómez-Guijarro; Lourdes Lacal; R N Clara Ferrero; Octavio Rodríguez Journal: J Atr Fibrillation Date: 2016-04-30
Authors: Emily N Guhl; Donald Siddoway; Evan Adelstein; Raveen Bazaz; George S Mendenhall; Jan Nemec; Samir Saba; David Schwartzman; Andrew Voigt; Norman C Wang; Sandeep K Jain Journal: J Am Heart Assoc Date: 2016-07-21 Impact factor: 5.501